secwatch / observer
8-K filed May 29, 2025 23:59 UTC ticker CL CIK 0000021665
leadership confidence high sentiment neutral materiality 0.55

Colgate-Palmolive appoints Shane Grant as COO Americas; Parameswaran retires

COLGATE PALMOLIVE CO

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shane Grant

Chief Operating Officer, Americas
CL · COLGATE PALMOLIVE CO
Effective
2025-06-16
Filed
May 29, 2025 23:59 UTC
the Company announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective June 16, 2025.
Role change

Prabha Parameswaran

Vice Chair
CL · COLGATE PALMOLIVE CO
Effective
2025-06-16
Filed
May 29, 2025 23:59 UTC
the Board has elected Ms. Parameswaran Vice Chair of the Company, effective June 16, 2025.
Role change

Panagiotis Tsourapas

Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
CL · COLGATE PALMOLIVE CO
Effective
2025-06-16
Filed
May 29, 2025 23:59 UTC
The Board also approved the promotion of Panagiotis Tsourapas to the position of Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
Role change

John Hazlin

Chief Growth Officer
CL · COLGATE PALMOLIVE CO
Effective
2025-06-16
Filed
May 29, 2025 23:59 UTC
and John Hazlin to the position of Chief Growth Officer
Departed

Prabha Parameswaran

Vice Chair
CL · COLGATE PALMOLIVE CO
Effective
2025-10-01
Filed
May 29, 2025 23:59 UTC
has communicated to the Company her intention to retire from the Company on October 1, 2025.
Source: SEC EDGAR
accession 0000021665-25-000025

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.